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Abstract
Background: Hopea Odorata, locally known as Telsur (Bangladesh), has some traditional uses as folk medicine. This
study aims to investigate the antioxidant, antidiarrheal, hypoglycemic and thrombolytic activities of H. odorata leaf
extracts as new therapeutic prospects predicting the activity of some of the isolated compounds of this plant.
Methods: Leaves of Hopea odorata was extracted with pure methanol (MEHO), ethanol (EEHO) and water (AEHO).
The extract was tested for antioxidant activity by using reducing power and H2O2 scavenging assay. Antidiarrheal
effects were assayed by three standard methods of bioassay: Castor oil-induced diarrhea, Castor oil induced
enteropooling and gastrointestinal transit test. Hypoglycemic effect was determined by normoglycemic model of
mice. Thrombolytic activity was evaluated by clot lyses test for human and mice blood. In silico PASS prediction
was applied for phytoconstituents namely Balanocarpol, Hopeaphenol and Ampelopsin H isolated from this plant.
Result: Among the all extracts, MEHO exhibited strong antioxidant activity in both reducing power and H2O2
scavenging assay. Phenol content of MEHO was 297.22 ± 0.78 mg/g and flavonol content was 91.53 ± 1.
82 mg/g. All the experiment of extracts at dose of 200 and 400 mg/kg and the standard drug loperamide
(5 mg/kg) showed significant (p < 0.001) inhibition against castor oil induced diarrhea and castor oil induced
enteropooling in mice. There were also significant (p < 0.01) reduction in gastrointestinal motility in the
charcoal meal test. Leaf extract showed no significant (P < 0.01) decrease of blood glucose compared to
Glibenclamide in normoglycemic mice. Using an in vitro thrombolytic model, MEHO showed the highest and
significant clot lysis of human and mice blood compared to Streptokinase. PASS predicted the wide range of
antioxidant, free radical scavenger, Nitric oxide scavenger, cardioprotectant, hepatoprotectant, thrombolytic,
fibrinolytic, antibacterial, antifungal, anticarcinogenic, anthelmintic and anti-inflammatory activity of examined
phytoconstituents.
Conclusion: These findings suggest that the plant may be a potential source of new antidiarrheal, thrombolytic and
antioxidative agents but it is found to have no antidiabetic capability. PASS prediction matched with present study for
the extracts. Further study needs to identify the PASS predicted biological actions of the phytoconstituents.
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Background
In recent time, phytomedicines has drawn special atten-
tion as therapeutics giving wide range of treatment
options against diseases. Sometimes they are more useful
than synthetic drugs due to their economic price, less
adverse effects and efficacy in multidrug resistant inci-
dences [1–3]. The greater efficiency of plant-derived
drugs is due to their antioxidative role which prevents
oxidation and provides protection to living organisms
from damage caused by uncontrolled production of ROS
and concomitant lipid peroxidation, protein damage and
DNA strand breaking. Protection of cellular oxidative
damage is, therefore, the pivotal mechanism for minim-
izing the occurrences of most of the diseases. This
hypothesis guides the natural drug scientists to search for
delicate sources of natural antioxidative agents those are
supporting different pharmacological actions in several
ailments. This study deals with the pharmacological
actions namely antidiarrheal, hypoglycemic and thrombo-
lytic effects of a newer source of indigenous medicinal
plant Hopea odorata.
Diarrhea is characterized by an increase in the fre-
quency of bowel movements, wet stool and abdominal
pains [4]. It is the world’s third highest killer disease,
contributing substantially to pediatric morbidity and
mortality, especially in the malnourished [5]. The preva-
lence and incidence of diarrhea over the world is still
high (about 7.1 million per year), despite the efforts of
different international organizations to control this
disease [6]. Antibiotics used as antidiarrheal drugs some-
times provoke adverse effects and microorganisms tend
to develop resistance toward them [7]. Therefore, the
search for safe and more effective agents from plant
origin, which has long been a very important source of
new drugs, has continued to be an important area of
antidiarrheal research. Especially the medicinal plants
are a promising source of antidiarrheal drugs [8]. There-
fore, international organizations including the World
Health Organization (WHO) have encouraged studies
pertaining to the treatment and prevention of diarrheal
diseases using traditional medical practices [9].
Diabetes mellitus, one of the five leading causes of death
in the world, is a major global health concerning with a
projected rise in the number of adults living with diabetes
has almost quadrupled since 1980 to 422 million adults.
[10]. It is a metabolic disorder usually caused due to the
combination of hereditary and environmental issues
resulting in hyperglycemia [11]. Despite considerable pro-
gress in the treatment of diabetes by oral hypoglycemic
agents, search for newer drugs continues because the
existing synthetic drugs have several limitations [11]. For
instance, the available synthetic antidiabetic agents pro-
duce serious side effects like hypoglycemia and hepatore-
nal disturbances [12]. Medicinal plants play a great role in
the traditional management of the disease due to their
relative safety and low cost. Scientific investigation into
some of these medicinal plants shows that they increase
insulin secretion enhance glucose uptake by adipose or
muscle tissues and inhibit glucose absorption from intes-
tine and glucose production from liver [13]. The World
Health Organization (WHO) has listed 21 000 plants,
which are used for medicinal purposes around the world
[14]. However, very few of these medicinal plants have
received scientific scrutiny. In our search for more potent
and safer antidiabetic principles, we are currently investi-
gating the hypoglycemic effect of H. odorata leaves
alcoholic extract.
Thrombosis is a lethal disease which is characterized
by the formation of blood clots (thrombus) in the circu-
latory system because of the imbalance of homeostatic
system of physiological procedures [15]. This is a serious
incident in the arterial diseases connected with acute
coronary disorders such as pulmonary emboli, deep vein
thrombosis, strokes, heart attacks, and venous thrombo-
embolic disorders that account for sudden morbidity
and mortality [16]. Thrombosis leads to vascular block-
ade and while recovering it causes fatal consequences,
such as cerebral or myocardial infarction and even death
[17]. Thrombolytic agents including tissue plasminogen
activator (t-PA), alteplase, anistreplase, urokinase (UK),
and streptokinase (SK) and recombinant t-PA therapies
have been used as effective treatment for thrombolysis.
But anaphylactic reaction, systemic fibrinolysis,
hemorrhage, slow reperfusion rate and frequent early
reocclusions limit the scopes of thrombolytic drugs in
many cases [18]. For that reason, alternatives options as
traditional and herbal drugs are highly necessitated and
numbers of plants have already been reported to show
very emerging and potential thrombolytic agents [19].
Hopea odorata belonging to the Dipterocarpaceae
family is locally known as Telsur (Bangladesh). It can
grow up to 120 feet to produce good quality timber. The
wood of H. odorata varies in color from a very pale
yellow, or white to brown when first cut and characteris-
tically darkens to a brownish or yellowish-brown color
after more or less prolonged exposure to the air. Differ-
ent parts of this plant have long been used as one of the
most important traditional medicinal sources in Indian
subcontinent. The dammar of this tree is said to have
medicinal property used in treating sores and wounds
[20]. The tannin rich bark and leaves of this plant have
been used for treating paralysis, haemorrhoids, diarrhea,
gum inflammation, and urinary incontinence [21]. The
stem bark of H. odorata has also been traditionally used
to treat neck pains in the North Andaman Islands, India
[22]. This plant contains various resveratrol derivatives,
including hopeaphenol, vaticanol B, hemsleyanol B, ste-
monoporal A, e-viniferin, and laevifonol. Phytochemical
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studies reported that the heartwood of H. odorata con-
tains certain types of phenolic compounds [23]. These
polyphenols are reported useful as antioxidants, antibac-
terial, anti-inflammatory, antimutagens, scavengers of
free radicals and therefore have implications in the pre-
vention of pathologies such as cancer and cardiovascular
disease [24]. Methanol extract of Hopea odorata sup-
presses inflammatory responses via the direct inhibition
of multiple kinases. Methanol extract also clearly sup-
presses the gene expression of pro-inflammatory cyto-
kines and chemokines, such as interferon (IFN)-b,
interleukin (IL)-12, and monocyte chemotactic protein-
1(MCP-1). The extract also ameliorates the inflamma-
tory symptoms in EtOH/HCl-induced gastritis and
arachidonic acid-induced earoedemas in mice. Leaves of
H. odorata has been reported to show antibacterial and
anthelmintic acitivity [25]. H. odorata is a folk medicine
and its wood has been used for treatment of yaws, blood
disorder, fever, and as expectorant. Its dried stem latex
was ground and used for wound healing [20].
Since an in vitro partial study (single fraction) on antiox-
idative and complete studies on anthelmintic effects of H.
odorata (L.) Scop. has been conducted, this research aims
to extend the antioxidative effects and investigate the anti-
diarrheal properties which are inevitably linked with
anthelmintic action. Researchers reported that “virtually
no intestinal worm has escaped the allegation of being a
cause of diarrhea and our plant has been found to be
anthelmintic” [26]. Additionally the helminthic infections
are linked to caloric restriction in insulin resistance state
either directly or indirectly via T-helper-2 polarization of
the immune system [27]. Therefore, the partial antioxida-
tive effects and anthelmintic studies in in vitro system led
us to go for an evaluation of in vivo antidiarrheal and
hypoglycemic effects. Traditional uses of this plant in
haemorrhoids and blood disorders also make us to
adjunct an investigation on the thrombolytic effects of
methanol, ethanol and aqueous extract of H. odorata
leaves. The research also works to predict the biological
activity of the isolated major compounds of this plant such
as Balanocarpol, Hopeaphenol and Ampelopsin H, com-
pounds by using in silico PASS prediction tools [28, 29].
Methods
Plant material
Fresh leaves of Hopea odorata were collected from the hilly
areas of University of Chittagong, Chittagong, Bangladesh
in the month of November 2014. It was authenticated by
Dr. Sheikh Bokhtear Uddin, Professor and taxonomist,
Department of Botany, University of Chittagong,
Chittagong-4331, Bangladesh. A voucher specimen of the
sample has been preserved as accession number AB-
5729CTGUH in the institutional of Herbarium of the
Department of Botany, University of Chittagong.
Preparation of Extract
The leaves were dried for 10 days under shade and
grounded. The resulting powder of leaves (400 g) were
soaked in 1.6 L methanol, ethanol and distilled water
separately for 1 week at room temperature (23 ± 1) °C with
occasional shaking and stirring. The whole mixture was
then filtered through Whatman filter paper No. 1 and the
filtrate thus obtained was concentrated using a rotary
evaporator (RE200, Bibby Sterling Ltd, UK) to get a
viscous mass which was kept at room temperature under
a ceiling fan to get a dried extract and found MEHO
(7.2%, W/W), EEHO (6%, W/W) & AEHO (8%, W/W).
Chemicals and reagents
All chemicals and reagents used in this research were of
analytical grade. Ethanol, chloroform, sulfuric acid, and
hydrochloric acid purchased from Merck -India). Gallic
acid, Folin-Ciocalteau reagent, trichloroacetic acid was
purchased from Sigma Chemicals Co. (P.O. Box 14508,
St. Louis, MO 63178 USA). 1,1-diphenyl-2-picrylhydra-
zyl (DPPH), aluminium chloride were purchased from
Fluka (Fluka chemie GmbH, CH-9471 Buchs). Ascorbic
acid, Quercetin, Tannic acid was purchased from BDH
Chemicals (BDH Chemicals Ltd. Poole, England). Ferric
chloride, potassium ferricyanide, sodium hydroxide and
sodium nitrite were purchased from Riedel-De Haen Ag,
Seelze-Hannover, Germany. Shimadzu Biospec 1601 UV
visible spectrophotometer (Shimadzu, Japan) was used
to measure the absorbance. Dimethyl sulfoxide (DMSO),
Loperamide (Square Pharmaceuticals Ltd., Bangladesh),
castor oil (WELL’s Heath Care, Spain), normal saline so-
lution (0.9% NaCl) and charcoal meal (10% activated
charcoal in 5% gum acacia) were also used in this
research.
Experimental animals
Six-seven weeks old Swiss albino mice of both sexes
with mean body weight 25 ± 5.0 g were procured from
Jahangir Nagar University, Savar, Bangladesh. The ani-
mals were housed as 4 in 1 polycarbonated cage in a
temperature (23 ± 1) °C and humidity (55–60%)-con-
trolled room with a 12-h light-dark cycle. Animals
were fed with a commercial rat pellet diet ad libitum
during the entire experimental period. The study
protocol was approved by the P&D Committee,
Department of Pharmacy, International Islamic Uni-
versity Chittagong, Bangladesh. Animals were handled
according to the rules and regulations of the Institu-
tional Animal Ethics Review Board of the Faculty of
Biological Sciences, University of Chittagong under
the approval number AERB/FBS/UC/05, 2015. Ethical
Review Board has approved to collect human blood
under the same ethical approval number.
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In vitro antioxidant activity
Reducing power capacity
The reducing power of the extract was evaluated using the
method of Oyaizu [30]. Briefly, Leave extracts of H.
odorata (125, 250, 500 and 1000 μg/mL) in 1 mL of
distilled water were mixed with phosphate buffer (2.5 mL,
0.2 M, pH 6.6) and potassium ferricyanide [K3Fe(CN)6]
(2.5 mL, 1% w/v). The mixture was incubated at 50 °C for
20 min. After incubation, 2.5 mL of 10% trichloroacetic
acid solution was added to each tube and the mixture was
centrifuged at 3000 rpm for 10 min. Subsequently, 5 mL of
the upper layer solution was mixed with 5 mL of distilled
water and 1 mL of ferric chloride solution (0.1% w/v), and
the absorbance was measured at 700 nm. The reducing
power of the extract was linearly proportional to the con-
centration of the sample. Ascorbic acid was taken as a
reference standard.
Hydrogen peroxide scavenging activity
Hydrogen peroxide scavenging activity of the plant extract
was estimated using the modified method described by
Oyedemi et al. [31]. Plant extract (4 mg/ml) prepared in
distilled water at various concentrations was mixed with
0.6 ml of 4 mM H2O2 solution prepared in phosphate buf-
fer (0.1 M pH 7.4) and incubated for 10 min. The absorb-
ance of the solution was measured at 230 nm (Shimadzu
Biospec 1601 UV visible spectrophotometer). The amount
of hydrogen peroxide radical inhibited by the extract was
calculated using the following equation: H2O2 radical
scavenging activity = [(Abs control - Abs sample)]/(Abs
control) × 100, where Abs control is the absorbance of
H2O2 radicals +methanol and Abs sample is the absorb-
ance of H2O2 radical + sample or extract or standard.
Determination of total phenolic content
Total phenolic content of all the extracts was evaluated
with Folin-Ciocalteau method [32]. Samples containing
polyphenols are reduced by the Folin-Ciocalteau reagent
there by producing blue colored complex. The phenolic
concentration of extracts was evaluated from a gallic
acid calibration curve. To prepare a calibration curve,
0.5 mL aliquots of 12.5, 25, 50, 100, 200, and 400 μg/mL
methanolic gallic acid solutions were mixed with 2.5 mL
Folin-Ciocalteau reagent (diluted ten-fold) and 2.5 mL
(75 g/L) sodium carbonate. After incubation at 25 °C for
30 min, the quantitative phenolic estimation was per-
formed at 765 nm (UV Spectrophotometer 1650
Shimadzu, Japan). The total content of phenolic com-
pounds was calculated in gallic acid equivalents (GAE)
using the formula: A = (CXV)/m; where A is the total
content of phenolic compounds, mg/g plant extract in
GAE; C is the concentration of gallic acid established
from the calibration curve, mg/ml; V is the volume of
extract in ml and m is the weight of plant extracting.
Determination of total flavonols
Total flavonol content was determined by adopting the
procedure described by Kumaran and Karunakaran [33].
The reaction mixture consisted of 2.0 ml of the sample,
2.0 ml of AlCl3 prepared in ethanol and 3.0 ml of (50 g/L)
sodium acetate solution. The absorbance at 440 nm was
measured after 2.5 h at 20 °C. Total flavonol content was
calculated as mg/g of quercetin equivalent from the cali-
bration curve using the equation: Y =0.0255x, R2 = 0.9812,
where x is the absorbance and Y is the quercetin
equivalent.
Determination of LD50 and rationalization of dosage.
For acute toxicity study, forty Swiss albino female mice
were used. According to the method of Walum et al.,
mice were divided into four groups of five animals each
[34]. Different doses (1000, 2000, 3000 and 4000 mg/kg)
of different extracts of H. odorata leaves were adminis-
tered by stomach tube. After administration, food was
withheld for further 3 to 4 h. Individual animal was kept
in close observation during the first 30 min after dosing,
periodically first 24 h (special attention for the first 4 h),
thereafter for a period of 3 days to record the delayed
toxicity. Once daily cage side observation including
changes in skin and fur, eyes and mucous membrane,
respiratory and circulatory rate, autonomic and CNS
changes were observed. The effective therapeutic dose
was taken as one tenth of the median lethal dose
(LD50 >2.0 g/kg) [35].
In vivo antidiarrheal activity
Castor oil-induced diarrhea
The experiment employed the method described by
Awouters et al. [36]. Mice were fasted for 18 h before
the test with free access to water and divided into five
groups of five animals each. Group I treated as normal
control (saline 2 ml/kg body weight p.o.), Group II
received reference drug (loperamide 5 mg/kg b. wt. p.o.),
Group III-IV received methanol extract (200 and
400 mg/kg b. wt. p.o.), Group V-VI received ethanol
extract (200 and 400 mg/kg b. wt. p.o.) and Group VII-
VIII received aqueous extract (200 and 400 mg/kg b. wt.
p.o.). Then 1 h later, castor oil was administered orally
to these animals to induce diarrhea. The mice were then
housed individually in cages lined with white blotting
paper. The papers were changed every hour. The total
number of both dry and wet feces excreted were
counted every hour for a period of 4 h and compared
with the control group. The total number of diarrheal
feces of the control group was considered 100%.
Castor oil-induced enteropooling
Intraluminal fluid accumulation was determined by the
method of Robert et al. [37]. Mice fasted for 18 h were
divided into five groups of five animals each. Group I
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served as control (saline 2 ml/kg body weight intraperi-
toneally), Group II received standard drug (loperamide
5 mg/kg b. wt. ip), Group III-IV received methanol
extract (200 and 400 mg/kg b. wt. p.o.), Group V-VI
received ethanol extract (200 and 400 mg/kg b. wt. p.o.)
and Group VII-VIII received aqueous extract (200 and
400 mg/kg b. wt. p.o.). Then 1 h later, castor oil was
administered orally to these animals to induce diarrhea.
Two hours later, the mice were sacrificed by overdose of
chloroform anesthesia, and the small intestine was
ligated both at the pyloric sphincter and at the ileocecal
junctions and dissected out. The small intestine was
weighed. The intestinal contents were collected by milk-
ing into a graduated tube and the volume was measured.
The intestines were reweighed and the differences
between full and empty intestines were calculated.
Gastrointestinal motility test
This experiment was carried out by the method
described by Mascolo et al. [38]. Mice were fasted for
18 h and divided into five groups of five animals each.
Castor oil was administered orally to these animals to
induce diarrhea. One hour later Group I received saline
2 ml/kg body weight intraperitoneally, Group II received
standard drug (loperamide 5 mg/kg b. wt. p.o.), Group
III-IV received methanol extract (200 and 400 mg/kg b.
wt. p.o.), Group V-VI received ethanol extract (200 and
400 mg/kg b. wt. p.o.) and Group VII-VIII received
aqueous extract (200 and 400 mg/kg b. wt. p.o.). One
hour after treatments (i.p), animals received 1 ml of
charcoal meal (10% charcoal suspension in 5% gum
acacia) orally. One hour later, the animals were sacrificed
by overdose of chloroform anesthesia and the distance
traveled by the charcoal meal from pylorus to caecum
was measured and expressed as a percentage of the total
distance of the intestine.
Hypoglycemic effect in normal mice
Hypoglycemic action of the extract was carried out by
established normoglycemic model [39]. Animals divided
into five groups were administered saline to Group I
(normal control group), glibenclamide (5 mg/kg body
weight) to Group II (positive control group), different
extracts (MEOH, EEOH and AEOH) at the dose of
800 mg/kg bw to Group III-V respectively. Before
administration of drug and extract solutions, 16 h fasting
blood glucose levels were estimated by glucose oxidase
method [40]. Then blood glucose levels were again esti-
mated after 2 h of administration of drug and extract
solutions. Glucose levels were measured by Rapid
ViewTM (Blood glucose monitoring system, Model: BIO-
M1, BIOUSA Inc, California, USA).
In vitro thrombolytic activity
Thrombolytic activity on human blood
Blood specimen Whole blood (2.5 ml) was drawn from
healthy human volunteers (n = 12) without a history of oral
contraceptive or anticoagulant therapy. A consent, ap-
proved by Mohammed Abu Sayeed, Assistant professor &
Head of Department of Pharmacy, International Islamic
University Chittagong, Bangladesh, for collection of blood
samples from Human volunteers. Blood was collected by
Md. Shariful Islam (Lab technician, Department of Phar-
macy, IIUC) and preserved by Abdul Karim (Lab techni-
cian, Department of Pharmacy, IIUC), who stored the clot
containing Eppendorf tube in the refrigerator in Microbiol-
ogy lab, Department of Pharmacy, IIUC and gave stored ID
as TAHO-06 after finish of the experiment. A 500 μl of
blood was transferred to each of the six previously weighed
Eppendorf tube tubes to form clots.
Statement on informed consent of the donors
The volunteers blood samples were collected under the
ethical approval number AERB/FBS/UC/05A, 2015 pro-
vided by the institutional ethical review board of the Uni-
versity of Chittagong. The volunteer donors were supplied
a consent form which informed the title of the research
project, name and detail contact of investigators as well as
purpose of the research. Description of the research men-
tioning step-by-step brief of the proposed research, inclu-
sion and exclusion criteria of the donors, whether donors
will receive any therapy or not, volume of blood to be
taken, possible discomfort of the puncture sites, time
required for the blood sampling. Benefits of the volunteer
described. It was indicated to the consent form that the
volunteers might refuse to donate blood at any time.
Donor whether could withdraw his sample data was dis-
closed. The sample was restricted for that individual study
not for future research projects was presented in the con-
sent form. Potential harm, injuries, discomforts or incon-
venience associated with donors in this study was added
as informed consent statement. If there was known harm
to the donors, the potential harm, current knowledge
regarding the probability of the occurrence of the harm,
clinical importance of the harm; and any relevant know-
ledge regarding the probability of reversibility. Treatment
alternative and possibility of the research was described.
Confidentiality statement was included in the consent
form in the way that “confidentiality will be respected and
no information that discloses the identity of the partici-
pant will be released or published without consent unless
required by law of states. Finally identification of investiga-
tors was provided in case of further query. The consent
form was concluded with major questions on above
disclosures in Yes/NO form followed by the signature
(with date) of the donor.
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In Vitro thrombolytic study procedure
Experiments for clot lysis were carried out as reported
earlier [41]. Briefly, 2.5 ml venous blood drawn from the
healthy volunteers was distributed in six different pre
weighed sterile Eppendorf tube (0.5 ml/tube) and incu-
bated at 37 °C for 45 min. After clot formation, serum
was completely removed without disturbing the clot and
each tube having clot was again weighed to determine
the clot weight (clot weight = weight of clot containing
tube - weight of tube alone). To each Eppendorf tube
containing pre-weighed clot, 100 μl of different extracts
of H. odorata leaves were added separately. As a positive
control, 100 μl of Streptokinase (SK) and as a negative
non-thrombolytic control, 100 μl of distilled water were
separately added to the control tubes numbered. All the
tubes were then incubated at 37 °C for 90 min and
observed for clot lysis. After incubation, fluid released
was removed and tubes were again weighed to observe
the difference in weight after clot disruption. Difference
obtained in weight taken before and after clot lysis was
expressed as percentage of clot lysis. The experiment
was repeated with the blood samples of the 20
volunteers.
Thrombolytic activity on mice blood
Blood specimen After the acclimatization 25 male mice
in animal lab, mice were sacrificed by overdose of chloro-
form anesthesia and 0.5 ml blood was withdrawn from
each mice. A 0.5 ml of blood was transferred to the 25
previously weighed Eppendorf tube tubes to form clots.
Procedure Experiments for clot lysis were carried with
modification of established protocol for mice reported
earlier [42]. The experiment was repeated five times with
total 25 mice.
In silico Prediction of activity spectra for substances
(PASS)
Drawing of the structures
The chemical structures of the Balanocarpol, Hopeaphenol
and Ampelopsin H, the compounds isolated from H. odor-
ata, were obtained from Pubchem compound repository
(http://www.ncbi.nlm.nih.gov/pccompound). The structures
were drawn using the Chem sketch package 11.0 belonging
to the ACD chem. Laboratory.
PASS prediction procedure
Prediction of phytoconstituents namely Balanocarpol,
Hopeaphenol and Ampelopsin H isolated from H. odor-
ata [43] for different activity like antioxidant, free radical
scavenger, Nitric oxide scavenger, cardioprotectant,
hepatoprotectant, thrombolytic, fibrinolytic, antibacter-
ial, antifungal, anticarcinogenic, antihelmintic and anti-
inflammatory was done with the help of computer pro-
gram, PASS (Prediction of activity spectra for sub-
stances). Software estimates predicted activity spectrum
of a compound as probable activity (Pa) and probable
inactivity (Pi). The prediction of activity is based on
structure-activity relationship analysis of the training set
containing more than 205,000 compounds exhibiting
more than 3750 kinds of biological activities. The values
of Pa and Pi vary between 0.000 and 1.000. Only activ-
ities with Pa > Pi are considered as possible for a particu-
lar compound. If Pa > 0.7, the probability of experimental
pharmacological action is high and if 0.5 < Pa < 0.7, prob-
ability of experimental pharmacological action is less. If
the value of Pa < 0.5, the chance of finding the activity
experimentally is less, but it may indicate a chance of
finding a new compound [44],.
Statistical analysis
Data were expressed as mean ± SEM. For in vitro anti-
oxidant assays one way ANOVA test using SPSS (Statis-
tical Package for Social Science, version 21.0, IBM
corporation, NY) followed by Tukey’s test (P < 0.05) was
used to analyze the differences among EC50 of various
extracts for different antioxidant assays. The EC50 values
were determined using the Graph Pad Prism6 software.
Statistical analysis was carried out with Dunnett’s test
using the statistical software SPSS for antidiarrheal,
hypoglycemic and thrombolytic activities. The results
obtained were compared with the negative control group
and P < 0.05 was considered to be statistically significant.
Results
Total phenols and flavones content
Total phenolic content of the different extracts of H.
odorata was found to be solvent dependent and
expressed as milligrams of gallic acid equivalents (GAE).
Table 1 summarizes that total phenolic compounds in
extracts varied widely, ranging from 66.11 ± 0.95 to
297.22 ± 0.78 mg/g gallic acid equivalents (GAE). MEHO
exhibited the highest total phenolic content. The content
of flavonoid expressed as quercetin equivalents, varied
Table 1 Total phenols and flavonols content of different
extracts of H. odorata
Extracts Total Phenol
(mg gallic acid /g)
Total Flavonol
(mg quercetin/g)
MEHO 297.22 ± 0.78a 91.53 ± 1.82a
EEHO 266.39 ± 0.68b 75.53 ± 0.22b
AEHO 66.11 ± 0.95c 40.34 ± 0.28c
Values are presented as mean ± SEM for triplicate. Data for total phenols and
flavonols of H. odorata extracts were processed by paired t- test using Statistical
package for social Science (SPSS for windows, version 21.0, IBM Corporation,
New York, USA) followed by Dunnet test. a, b & c superscript letters in the table
are significantly different from each other. Values with P < 0.05 were considered
as significant
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from 40.34 ± 0.28 to 91.53 ± 1.82 mg quercetin equiva-
lent/g extract (Table 1). The MEHO also showed the
highest amount of flavonoid contents.
Reducing power capacity
Data for the reducing powers of H. odorata extracts
were shown in Fig. 1. A dose dependent reducing cap-
ability was observed in reducing power assay. The rank-
ing order for reducing power was MEHO > EEHO >
AEHO indicating the highest reducing power of AEHO
which was found to show the reducing power 1.30 ±
0.02. And this value was statistically significant com-
pared to that of reference reducing agent AA. Two other
treatments MEHO and EAHO showed the reducing
power 8.29 ± 0.02 and 3.02 ± 0.05 respectively.
Hydrogen peroxide scavenging activity
The scavenging effect of H. odorata extracts on hydro-
gen peroxide was concentration-dependent (10–160 μg/
ml) as shown in Fig. 2. MEHO displayed strong H2O2
scavenging activity (EC50 38.31 ± 0.27 μg/ml) whereas
that of the standard, ascorbic acid exhibited 10 ± 0.3 μg
/ml. The scavenging activities of EEHO and AEHO were
(EC50 62.42 ± 0.09 μg/ml and 88.31 ± 0.23 μg/ml,
respectively). EC50 values of the extracts in scavenging
hydrogen peroxide were significantly different (P < 0.001)
from the EC50 values obtained for ascorbic acid. The
scavenging activity for hydrogen peroxide of various
extracts from H. odorata was in the order of MEHO >
EEHO >AEHO respectively.
LD50 and rationalization of dosage
None of the animals showed behavioral, neurological
or physical changes characterized by symptoms such
as reduced motor activity, restlessness, convulsions,
coma, diarrhea and lacrimation at the limit dose of
4000 mg/kg of different extracts of H. odorata during
the observation period. In addition, no mortality was
observed at the test dose. Thus, the median lethal
dose (LD50) of the plant extract was found to be greater
than 4000 mg/kg.
Castor oil-induced diarrhea
Results for castor-oil induced diarrhea are summarized
in Table 2. All the extracts of H. odorata leaves were
found to be effective in a dose dependent manner
against castor oil induced diarrhea on experimental mice
at all tested doses. At the dose of 400 mg/kg body
weight of every extract produced a significant decrease
in the severity of diarrhea in terms of reduction in the
rate of defecation and consistency of faeces in albino
mice. At the same dose, the extracts showed significant
antidiarrheal activity (P < 0.001) showing 56.72 ± 5.48%,
58.21 ± 6.92% and 47.76 ± 2.36% reductions in diarrhea
respectively in MEHO, EEHO and AEHO comparable to
that of the standard drug loperamide that showed 59.70
± 2.99% reductions in diarrhea.
Castor oil-induced enteropooling
As demonstrated in Table 3, all test doses of the extract
significantly reduced the intestinal weight and volume in
dose dependent manner. Castor oil caused accumulation
of water and electrolytes in intestinal loop. Treatment
with the H. odorata leave extracts (200 and 400 mg/kg)
produced a significant (P < 0.05) inhibition of 45.57 ±
1.75%, 46.23 ± 0.96% and 38.03 ± 2.81% of intestinal con-
tent respectively in MEHO, EEHO and AEHO at
400 mg/kg body weight comparable to that of the stand-
ard drug loperamide which showed 59.70 ± 2.99% inhib-
ition of intestinal content (Table 4).
Fig. 1 Reducing power capacity of H. odorata extracts and ascorbic acid. Values are expressed as mean ± SEM for triplicate. Data were processed
by paired t-test analysis using Statistical package for social Science (SPSS for windows, version 21.0, IBM Corporation, New York, USA) followed by
Dunnet test. a, b, c & d superscript letters are statistically significant to each other. Values with P < 0.05 are considered as statically significant
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Gastrointestinal motility
The effect of H. odorata extract on the intestinal transit is
depicted in Table 4. All doses of the extracts were success-
ful to produce significant alteration in the % intestinal mo-
tility compared to the normal control. The normal control
(saline) resulted in 84.85 ± 2.88% intestinal motility by the
marker-charcoal meal. The 200 and 400 mg/kg oral dose
of the extracts exhibited 51.51 ± 0.97% to 62.05 ± 1.41% in-
testinal motility (Table 5). And the extracts significantly
inhibited 22.82 ± 1.76% to 35.93 ± 1.21% of intestinal mo-
tility at all the doses. However, the standard drug, Lopera-
mide (5 mg/kg) demonstrated a significant inhibition
(43.6 ± 2.14%) in intestinal motility.
Hypoglycemic effect
Data for hypoglycemic effects of H. odorata are pre-
sented in Table 5. At 800 mg/kg dose of H. odorata
extracts leave showed no hypoglycemic activity, i.e. they
didn’t reduce fasting blood glucose level rather fasting
blood glucose level was somewhat increased with the ad-
ministration of H. odorata extracts. However, glibencla-
mide significantly (P < 0.01) reduced fasting blood
glucose level.
In vitro thrombolysis
Table 6 summarizes the thrombolytic effects of H. odor-
ata extracts both on human and animal blood. In
thrombolytic approach with human blood sample,
addition of 100 μL streptokinase showed 76 ± 1.13% clot
lysis. On the other hand, distilled water was treated as
negative control which showed only 6.8 ± 1.38%, a negli-
gible clot lysis. MEHO showed the highest significant
(52.88 ± 4.1%) clot lysis activity among all the extracts (P
< 0.001). EEHO and AEHO respectively showed 24.92 ±
Table 2 The effect of H. odorata extracts on faces count in castor oil-induced diarrhea in mice
Treatment/Dose Total number of feces % Inhibition of defecation Total number of diarrheal feces % Inhibition of diarrhea
Saline 13.4 ± 0.24 5.8 ± 0.2
Loperamide 5.4 ± 0.40a 59.70 ± 2.99 2.2 ± 0.37a 62.07 ± 6.45
MEHO200 8.6 ± 0.24a 35.82 ± 1.83 3.6 ± 0.24a 37.93 ± 4.22
MEHO400 5.8 ± 0.73b 56.72 ± 5.48 2.6 ± 0.24b 55.17 ± 4.22
EEHO200 8.4 ± 0.24a 37.31 ± 1.83 3.4 ± 0.24c 41.38 ± 4.22
EEHO400 5.6 ± 0.92b 58.21 ± 6.92 2.4 ± 0.40c 58.62 ± 6.90
AEHO200 9.2 ± 0.37c 31.34 ± 2.79 4.2 ± 0.20c 27.59 ± 3.45
AEHO400 7.0 ± 0.31d 47.76 ± 2.36 3.2 ± 0.20d 44.83 ± 3.45
Values are presented as mean ± SEM for 5-6 rats. Data for the total number of feces and total number of diarrheal feces by H. odorata extracts, positive antidiarrheal
control (Loperamide, 5 mg/kg p.o.) and normal control (saline) were processed by paired t-test analysis using Statistical package for social Science (SPSS for windows,
version 21.0, IBM Corporation, New York, USA) followed by Dunnet test. a, b, c & d superscript letters in the table are statistically significant to each other. Values with
P < 0.05 are considered as statistically significant
Fig. 2 H2O2 scavenging effect of H. odorata extracts and ascorbic acid. Values are expressed as mean ± SEM for triplicate. Data for scavenging
effect by extracts and positive control (AA) were processed by paired t- test using Statistical package for social Science (SPSS for windows, version
21.0, IBM Corporation, New York, USA) followed by Dunnet test. a, b, c & dsuperscript letters on the line graph are significantly different from each
other. Values with P < 0.05 were considered as significant
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2.44% and 38.25 ± 2.25% of clot lysis. Percentages of clot
lysis obtained after treating the clots with different ex-
tracts and appropriate controls are shown in Table 7 and
their comparison was represented in Fig. 3.
Methanol extract of H. odorata (MEHO) showed the
highest significant (61.34 ± 2.23%) clot lysis activity
among all the extracts (P < 0.001) and the value was sta-
tistically significant compared to that of Streptokinase
which showed 88.25 ± 1.42% clot lysis. EEHO showed
29.16 ± 2.58% of clot lysis and its P value was 0.001 and
AEHO showed 44.48 ± 2.04% of clot lysis and its P value
was 0.01. Percentages of clot lysis obtained after treating
the clots with different extracts and appropriate controls
are shown in Table 7 and their comparison was repre-
sented in Fig. 3.
In silico PASS prediction
Three phytoconstituents namely Balanocarpol, Hopea-
phenol and Ampelopsin H were analyzed by the PASS
for their different types of biological activity and results
were used in a flexible manner. All the compounds
showed greater Pa than Pi (Table 7). Balanocarpol
showed highest Pa for almost seven biological activities
at range 0.227–0.627 and showed near highest Pa value
for other five biological activities at range 0.239–0.692.
But it exhibited low Pa value for anthelmintic activity.
Hopeaphenol and Ampelopsin H exhibited same Pa and
Pi value for some biological activity. Pa and Pi values for
different activities of examined phytoconstituents are
presented in Table 7.
Discussion
Medicinal plants have recently drawn much attention of
the scientists due to the strong healing effect with no or
less adverse effects. The present investigation has ex-
plored the use of a medicinal plant (H. odorata) as anti-
oxidant, antidiarrheal, hypoglycemic and thrombolytic
properties. Antioxidants fight against free radicals play-
ing a definite role in numerous pathological demonstra-
tionsand protects us from different diseases. They exert
their action either by scavenging the reactive oxygen
Table 4 The effect of H. odorata extracts on intestinal transit in
mice using charcoal meal as a marker
Treatment/Dose % of intestine cross by marker % of inhibition
Saline 84.85 ± 2.88
Loperamide 45.35 ± 1.72a 43.6 ± 2.14
MEHO200 59.89 ± 0.51b 25.63 ± 0.63
MEHO400 52.72 ± 1.11b 34.43 ± 1.38
EEHO200 57.15 ± 0.81b 28.1 ± 1.01
EEHO400 51.51 ± 0.97b 35.93 ± 1.21
AEHO200 62.05 ± 1.41b 22.82 ± 1.76
AEHO400 55.04 ± 1.54b 31.54 ± 1.91
Values are presented as mean ± SEM for 5-6 rats. Data for % of intestine cross
by H. odorata extracts, positive antidiarrheal control (Loperamide, 5 mg/kg
p.o.) and normal control (saline) were processed by paired t-test analysis using
Statistical package for social Science (SPSS for windows, version 21.0, IBM
Corporation, New York, USA) followed by Dunnet test. a & b superscript letters
are statistically significant to each other. Values with P < 0.05 are considered
as statistically significant
Table 5 Effect of H. odorata extracts on fasting blood glucose
level (mmol/L) in normal mice






10 ml/kg 3.48 ± 0.11 4.29 ± 0.26
Glibenclamide 5 mg/kg 4.04 ± 0.09a 2.70 ± 0.18a
MEHO 800 mg/kg 4.48 ± 0.36 6.26 ± 0.31a
EEHO 800 mg/kg 4.54 ± 0.22a 5.98 ± 0.12a
AEHO 800 mg/kg 4.52 ± 0.11b 5.30 ± 0.09
Values are presented as mean ± SEM for 5-6 rats. Data for blood glucose
concentrations were processed by paired t-test analysis by using Statistical
Package for Social Science (SPSS for windows, version 21.0, IBM Corporation,
New York, USA) followed by Dunnet test. a & b superscript letters are statistically
significant to each other. Values with P < 0.05 are considered as
statistically significant
Table 3 The effect of H. odorata extracts on castor oil induced enteropooling in mice
Treatment/Dose Volume of intestinal content (ml) Weight of intestinal content (g) % Inhibition of intestinal content
Saline 0.24 ± 0.013 0.628 ± 0.033
Loperamide 0.13 ± 0.001 0.316 ± 0.002a 48.2 ± 0.40
MEHO200 0.17 ± 0.007 0.396 ± 0.016b 35.08 ± 2.67
MEHO400 0.14 ± 0.005 0.332 ± 0.010a 45.57 ± 1.75
EEHO200 0.17 ± 0.004 0.388 ± 0.011b 36.39 ± 1.83
EEHO400 0.14 ± 0.003 0.328 ± 0.006a 46.23 ± 0.96
AEHO200 0.19 ± 0.004 0.428 ± 0.009b 29.84 ± 1.41
AEHO400 0.16 ± 0.007 0.378 ± 0.017a 38.03 ± 2.81
Values are presented as mean ± SEM for 5-6 rats. Data for the weight of intestinal content (g) by H. odorata extracts, positive antidiarrheal control (Loperamide,
5 mg/kg p.o.) and normal control (saline) were processed by paired t-test analysis using Statistical package for social Science (SPSS for windows, version 21.0, IBM
Corporation, New York, USA) followed by Dunnet test. a & b superscript letters are statistically significant to each other. Values with P < 0.05 are considered as
statistically significant
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species or protecting the antioxidant defense mecha-
nisms [45]. The most natural antioxidants are multifunc-
tional. Therefore, a reliable antioxidant evaluation
protocol requires different antioxidant activity assessments
to account various mechanisms of antioxidant action.
Polyphenols were found in all the extracts of H. odor-
ata leaves. These polyphenolics are important dietary
antioxidants because they have ideal chemical structures
for free radical scavenging activities, and have been
shown to be more effective antioxidants in vitro than
vitamins E and C on a molar basis [46]. Our findings
suggested that leaves of H. odorata rich in phenolic and
flavonol contents which are the major contributor to
scavenge the free radicals in oxidation pathways.
The reducing power of all extracts was determined by
direct electron donation in the reduction of ferri cyanide
[Fe(CN)6]
3- to ferro cyanide [Fe(CN)6]
4-. The presence
of reductant (i.e. antioxidants) in H. odorata leaves cause
the reduction of the Fe3+ /ferricyanide complex to the
ferrous form which was monitored by measuring the
formation of Perl’s Prussian blue at 700 nm. The highest
reducing power of MEHO at all the tested concentrations
might be due to the phenolic compounds, especially Bala-
nocarpol, Hopeaphenol and Ampelopsin H the major
compounds of H. odorata, playing pivotal role in reducing
power of the extracts. [47].
Hydrogen peroxide scavenging assay is one of the
promising biologically important antioxidative assays.
H2O2 is rapidly decomposed into oxygen and water pro-
ducing hydroxyl radicals (•OH) that can initiate lipid
peroxidation and cause DNA damage [48]. Methanol
extract of H. odorata efficiently scavenged hydrogen per-
oxide which may be attributed to the presence of phen-
olic groups that could donate electrons to hydrogen
peroxide, thereby neutralizing it into water.
In antidiarrheal screening, castor oil is known to cause
water and electrolyte permeability changes in the intes-
tinal mucosal membranes, resulting in fluid and watery
luminal content that flow rapidly through the small and
large intestines [49]. The induction of diarrhea by castor
oil is attributed to its active ingredient ricinoleic acid
which stimulates the production of several inflammatory
mediator substances that include prostaglandins, nitric
oxide, and platelet activating factor, cAMP, histamine
and tachykinins [50]. The mediators thus released pro-
mote vasodilatation, smooth muscle contraction, and
mucus secretion in the small intestines. The inhibition
of castor-oil induced diarrhea can therefore be linked
with the inhibition of the synthesis of all or either of
those mediators by the experimental extract. In the
enteropooling study, the plant extract also dose-
dependently and significantly inhibited all the diarrheal
parameters (onset, frequency and severity of diarrhea,
total number of stools, number of wet stools, weight of
wet stools, etc.). This significant inhibition of entero-
pooling, therefore, suggests that the extract probably
produces relief in diarrhea through its spasmolytic and
anti-enteropooling effects. The intraluminal fluid accu-
mulation induced by castor oil was also blocked by the
extract in a dose-related manner. Although the exact
mechanism of the antidiarrheal action of H. odorata
could not be established in this study, a number of
Table 6 In vitro clot lysis activity of H. odorata extracts and Streptokinase on human and mice blood
Drug/Extracts % of clot lysis for human blood P value (two-tailed) when
compared to negative control
% of clot lysis for mice blood P value (two-tailed) when
compared to negative control
H2O 06.80 ± 1.38 - 9.06 ± 1.76
SK 76.00 ± 1.13c P < 0.001 88.25 ± 1.42c P < 0.001
MEHO 52.88 ± 4.1c P < 0.001 61.34 ± 2.23c P < 0.001
EEHO 24.92 ± 2.44a P < 0.05 29.16 ± 2.58c P < 0.001
AEHO 38.25 ± 2.25c P < 0.001 44.48 ± 2.04b P < 0.01
Values are mean ± SEM for 20 volunteers. Data for the effective clot lysis percentage by extracts, positive control (streptokinase) and normal control (distilled
water) were processed by paired t-test analysis using Statistical package for social Science (SPSS for windows, version 21.0, IBM Corporation, New York, USA)
followed by Dunnet test. a, b & c superscript letters are statistically significant to each other. Values with P < 0.05 are considered as statistically significant
Table 7 PASS prediction data biological activities of
Balanocarpol, Hopeaphenol and Ampelopsin H
Biological activity PASS predictions
Balanocarpol Hopeaphenol Ampelopsin H
Pa Pi Pa Pi Pa Pi
Antioxidant 0.597 0.005 0.515 0.006 0.497 0.007
Free radical scavenger 0.616 0.005 0.549 0.008 0.504 0.01
Nitric oxide scavenger 0.227 0.031 0.221 0.035 0.221 0.035
Cardioprotectant 0.289 0.092 0.294 0.088 0.294 0.088
Hepatoprotectant 0.379 0.036 0.369 0.038 0.369 0.038
Thrombolytic 0.692 0.042 0.730 0.038 0.708 0.051
Fibrinolytic 0.675 0.033 0.690 0.026 0.690 0.026
Antibacterial 0.578 0.006 0.313 0.097 0.446 0.066
Antifungal 0.466 0.004 0.250 0.106 0.234 0.116
Anticarcinogenic 0.627 0.011 0.470 0.022 0.431 0.026
Antihelmintic 0.185 0.107 0.331 0.081 0.331 0.081
Antiinflammatory 0.239 0.226 0.274 0.188 0.286 0.175
Bold text indicates the highest probability of activity (Pa) for each
biological activity
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investigators have shown the flavonoids, triterpenoids,
saponins, especially flavonoid possesses ability to inhibit
intestinal motility and hydroelectrolytic secretions which
are known to be altered in diarrheic conditions [51].
Since H. odorata is known to contain high content of
resveratrol derivatives those are stilbenoid and obtained
from same substrate of flavonoid giving very strong anti-
oxidative character, it is not unreasonable to speculate
that they could have contributed to the observed anti-
diarrheal effect of the plant.
In the hypoglycemic activity test extracts of H. odora-
taexerted no hypoglycemic effect after 2 h of administra-
tion implying the absence of the extract metabolites could
function to lower the blood glucose level at least in this
experiment. Glibenclamide, stimulator of insulin secretion
from β-cells islets of Langerhans, significantly reduced the
blood glucose level but no significant glucose lowering
effect was observed for the fractions of H. odorata demon-
strating that the beta cells were not sensitized enough to
secret insulin from β-cells by the extract.
Thrombolytic drugs block the pathway of thrombus
formation with the help of plasmin that lyses clot by
breaking down the fibrinogen and fibrin contained in a
clot. Commercial thrombolytic drugs especially strepto-
kinase converts plasminogen to plasmin through the and
thereby increases clot lysis. Scientists reported that
flavonoids, among the plant metabolites, affect throm-
bosis and cardiovascular disease by interfering with
platelet activation which a potential risk factor for
cardiovascular disease [52]. High content of H. odorata
is very much consistent with the previous report imply-
ing the role of H. odorata especially MEHO in clot lysis.
Additionally the comparison of positive control with
negative control clearly demonstrated that clot lysis does
not occur with the addition of water in our experiment.
The PASS prediction test for Balanocarpol, Hopea-
phenol and Ampelopsin H isolated from H. odorata
showed very good prospects and possibilities for
thrombolytic activity with wide range of Pa value as
0.662–0.730. It is reported that there are bacterial
contaminants of plants which have plasminogen
receptors that bind plasminogen. Cell surface bound
plasminogen is easily activated to plasmin, which
could lead to fibrinolysis [53]. H. odorata has moder-
ate antibacterial activity [54]. Bacterial plasminogen
activator: staphylokinase, streptokinase, act as cofactor
molecules that contribute to exosite formation and
enhance the substrate presentation to the enzyme.
Staphylokinase activates plasminogen to dissolve clots,
also destroys the extracellular matrix and fibrin fibers
that hold cells together [55]. However the thromboly-
sis on human and mice blood differs, which is
expected, due to the significant differences between
mice and humans in immune system development,
activation, and response to challenge, in both the
innate and adaptive arms. The differences are quite
helpful to validate the experimental procedure, tech-
nical drawbacks and efficacy of the therapeutics.
In order to accelerate the research for potent
natural products, computer-aided drug discovery pro-
gram PASS was used to predict the biological activity.
PASS prediction tools were constructed using 20,000
principal compounds [42]. The result of prediction is
presented as the list of activities with appropriate Pa
and Pi ratio. In the prediction of biological activity of
the examined phytoconstituents, Balanocarpol showed
maximum Pa value 0.227–0.627 for antioxidant, free
radical scavenger, nitric oxide scavenger, hepatopro-
tectant, antibacterial, antifungal and anticarcinogenic.
Hopeaphenol and Ampelopsin H both exhibited
Fig. 3 Comparative clot lysis by the controls and H. odorata extracts on both human and mice blood. Values are expressed as mean ± SEM. Data
for clot lysis percentage were processed by paired t- test using Statistical package for social Science (SPSS for windows, version 21.0, IBM
Corporation, New York, USA) followed by Dunnett test. a & b superscript letters on the graph bars are significantly different from each other.
Values with P < 0.05 were considered as significant
Kabir et al. BMC Complementary and Alternative Medicine  (2016) 16:474 Page 11 of 13
maximum probability for cardioprotectant (Pa =
0.294), fibrinolytic (Pa = 0.690) and antihelmintic (Pa
= 0.331). Alone Hopeaphenol exhibited maximum
probability for thrombolytic (Pa = 0.730) and ampelop-
sin H for anti-inflammatory (Pa = 0.286) action.
Conclusions
These findings suggest that the plant may be a potential
source for the development of new antidiarrheal drug.
Also data from present results revealed that H. odorata
act as an antioxidant agent due to its H2O2 scavenging
and thrombolytic activity. Though this plant has not
been found to be hypoglycemic in normoglycemic
model, it may be further studied in diabetic model to
confirm. Further research may result H. odorata as good
source of natural antioxidant, antidiarrheal and
thrombolytic drug. PASS prediction matched with
present study for the extracts. So further study need to
identify the activity as PASS predicted for the
phytoconstituents.
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